Avanos Medical (AVNS) Total Non-Current Liabilities (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Total Non-Current Liabilities data on file, last reported at $253.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 3.79% year-over-year to $253.9 million; the trailing twelve-month figure through Mar 2026 stood at $253.9 million (down 3.79% YoY), and the FY2025 full-year result was $282.0 million, down 12.23% from the prior year.
• Total Non-Current Liabilities retreated to $253.9 million in Q1 2026, from $282.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $487.2 million in Q3 2023 to a low of $253.9 million in Q1 2026.
• A 5-year average of $388.1 million and a median of $420.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities jumped 48.48% in 2022 and sank 39.24% in 2025, its largest moves.
• Tracing AVNS's Total Non-Current Liabilities over 5 years: stood at $475.2 million in 2022, then decreased by 6.12% to $446.1 million in 2023, then dropped by 27.98% to $321.3 million in 2024, then retreated by 12.23% to $282.0 million in 2025, then decreased by 9.96% to $253.9 million in 2026.
• Business Quant data shows AVNS's Total Non-Current Liabilities at $253.9 million in Q1 2026, $282.0 million in Q4 2025, and $269.0 million in Q3 2025.